FDA
TALK PAPER

Food and Drug Administration
U.S. Department of Health and Human Services
Public Health Service 5600 Fishers Lane Rockville, MD 20857

FDA Talk Papers are prepared by the Press Office to guide FDA personnel in responding with consistency and accuracy to questions from the public on subjects of current interest. Talk Papers are subject to change as more information becomes available.
 
  
  T99-23                    Print Media:         301-827-6242
  May 21, 1999              
                            Consumer Inquiries:  888-INFO-FDA
  
  
  

SUNSCREEN REGULATIONS FINALIZED

The Food and Drug Administration today finalized its regulations for over-the-counter (OTC) sunscreen drug products. The regulations (referred to as a "final monograph") list the sunscreen active ingredients that can be used in these products as well as labeling and testing requirements. The regulations provide for uniform, streamlined labeling for all OTC products intended for use as sunscreens to assist consumers in making decisions on sun protection.

FDA has been involved with the development of regulations for OTC drug products since 1972, and sunscreens is just one of many categories of OTC drug products for which "monographs" have been finalized.

Highlights of the new regulations include the following:

Because of the testing requirements for and seasonal nature of sunscreen products, manufacturers of sunscreens will have 24 months to comply with the new requirements. Manufacturers of cosmetic tanning preparations that do not contain a sunscreen will have 12 months to include the required warning statement on their products. However, all manufacturers are encouraged to provide the new labeling as soon as possible.

Claims concerning ultraviolet A (UVA) protection will continue as previously proposed until the agency further evaluates this issue.

####

Link to FDA HOME PAGE